The U.S. Food and Drug Administration (FDA) this week approved GSK‘s 200 mg/mL autoinjector of Benlysta (belimumab) for use ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Federal authority to regulate cosmetics remained largely unchanged until, on December 29, 2022, President Biden signed the ...

Smucker says goodbye to synthetic dyes in popular products by 2027, including jams, ice cream toppings, and Hostess snacks ...

House Bill 2516, also known as the PFAS Reduction Act, will stop numerous household items containing PFAS from being sold in ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...

A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

After decades of research, the U.S. Food and Drug Administration (FDA) has approved a test that can detect the buildup of amyloid plaques in the brain—a key marker of Alzheimer’s disease, ...

The Trump administration continued to reshape U.S. health policy in recent days with several moves that could change what vaccines people can get to protect themselves from common illnesses.